We serve Chemical Name:1-(3,4-DICHLOROPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID CAS:91064-25-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-(3,4-DICHLOROPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID
CAS.NO:91064-25-4
Synonyms:1-(3,4-DICHLOROPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID
Molecular Formula:C11H9Cl2NO3
Molecular Weight:274.10000
HS Code:2933790090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:57.61000
Exact Mass:272.99600
LogP:2.49590
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-(3,4-DICHLOROPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-(3,4-DICHLOROPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3,4-DICHLOROPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID Use and application,1-(3,4-DICHLOROPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID technical grade,usp/ep/jp grade.
Related News: Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology. 1-(3,4-DICHLOROPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID manufacturer Later on Friday, Canada’s drug regulator said it would not release J&J’s shipment of 300,000 COVID-19 vaccine doses, which were made at the Baltimore plant. 1-(3,4-DICHLOROPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID supplier The national airlines of Egypt, Qatar and Saudi Arabia have halted flights to and from China. 1-(3,4-DICHLOROPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID vendor Financial toxicity (FT) is more prevalent among individuals with atherosclerotic cardiovascular disease (ASCVD) than individuals with cancer, according to a study published in the June 1 issue of JACC: CardioOncology. 1-(3,4-DICHLOROPHENYL)-5-OXO-3-PYRROLIDINECARBOXYLIC ACID factory Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.
